FBInvestor
Stocks / Halozyme Therapeutics Inc
Institutional Ownership

Halozyme Therapeutics Inc

CUSIP 40637HAF6NOTE 1.000% 8/1HALOQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon